Education
About Us
Working with TipRanks
Follow Us
Paxman AB (SE:PAX)
:PAX
PAX Stock Chart & Stats
kr54.40
-kr1.20(-1.81%)
At close: 4:00 PM EST
kr54.40
-kr1.20(-1.81%)
Day’s Range― - ―
52-Week Rangekr44.20 - kr85.80
Previous CloseN/A
Volume3.13K
Average Volume (3M)100.37K
Market Cap
kr1.12B
Enterprise Valuekr1.05B
Total Cash (Recent Filing)kr129.53M
Total Debt (Recent Filing)kr10.72M
Price to Earnings (P/E)185.0
Beta-0.01
Next Earnings
Feb 27, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding23,273,417
10 Day Avg. Volume41,338
30 Day Avg. Volume100,373
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)7.61
Price to Sales (P/S)4.93
P/FCF Ratio78.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginA 68.3% gross margin indicates durable product-level profitability and pricing power for Paxman’s scalp cooling systems. High gross margins provide room to absorb SG&A or R&D investment, support sustained margins even if some cost pressure appears, and enable reinvestment to drive long-term adoption.
Low Financial LeverageVery low debt-to-equity gives Paxman financial flexibility and low interest burden, allowing capital allocation to growth initiatives or geographic expansion without strain. This conservatism reduces refinancing risk and enhances resilience across economic cycles over the coming months.
Recurring & Service Revenue MixA revenue mix of sales, rentals and maintenance creates recurring revenue and customer stickiness with hospitals and clinics. Service and rental streams smooth revenue volatility, improve lifetime customer value, and support predictable installed-base monetization over multi‑period adoption cycles.
Bears Say
Negative Free Cash FlowNegative free cash flow despite positive operating cash flow signals cash absorption from capex, working capital or investments. Persistent negative FCF constrains self‑funded growth, may force external financing, and reduces runway for marketing or international rollouts unless cash generation improves.
Declining Net Profit MarginA sharp drop in net margin points to rising operating expenses, pricing pressure, or one‑off costs that materially reduce retained earnings. Lower net profitability limits internal funding for R&D and expansion, increases sensitivity to revenue swings, and requires structural cost or pricing responses to restore margins.
Large EPS DeclineAn ~80% decline in EPS indicates material deterioration in bottom‑line performance, raising concerns about earnings volatility and operational efficiency. Such a steep EPS drop can impair investor confidence, make capital raising more costly, and signal the need for management actions to stabilize profitability.
Paxman AB News
PAX FAQ
What was Paxman AB’s price range in the past 12 months?
Paxman AB lowest stock price was kr44.20 and its highest was kr85.80 in the past 12 months.
What is Paxman AB’s market cap?
Paxman AB’s market cap is kr1.12B.
When is Paxman AB’s upcoming earnings report date?
Paxman AB’s upcoming earnings report date is Feb 27, 2026 which is in 8 days.
How were Paxman AB’s earnings last quarter?
Paxman AB released its earnings results on Nov 14, 2025. The company reported kr0.1 earnings per share for the quarter, beating the consensus estimate of kr0 by kr0.1.
Is Paxman AB overvalued?
According to Wall Street analysts Paxman AB’s price is currently Overvalued.
Does Paxman AB pay dividends?
Paxman AB does not currently pay dividends.
What is Paxman AB’s EPS estimate?
Paxman AB’s EPS estimate is 0.
How many shares outstanding does Paxman AB have?
Paxman AB has 23,273,417 shares outstanding.
What happened to Paxman AB’s price movement after its last earnings report?
Paxman AB reported an EPS of kr0.1 in its last earnings report, beating expectations of kr0. Following the earnings report the stock price went down -6.192%.
Which hedge fund is a major shareholder of Paxman AB?
Currently, no hedge funds are holding shares in SE:PAX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Paxman AB
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
PAX Earnings Call
Q3 2025
0:00 / 0:00